PAIN RELIEVER & SLEEP AID TABLET
Страна: Канада
Език: английски
Източник: Health Canada
Данни за продукта
(SPC)
30-09-2020
Понастоящем някои документи за този продукт не са налични, можете да изпратите заявка до нашата служба за клиенти и ние ще ви уведомим веднага щом успеем да ги получим.
Изпрати заяв.
Изпрати заяв.
Активна съставка:
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Предлага се от:
APOTEX INC
АТС код:
M01AE57
INN (Международно Name):
NAPROXEN AND DIPHENHYDRAMINE
дозиране:
25MG; 220MG
Лекарствена форма:
TABLET
Композиция:
DIPHENHYDRAMINE HYDROCHLORIDE 25MG; NAPROXEN SODIUM 220MG
Начин на приложение:
ORAL
Броя в опаковка:
100
Вид предписание :
OTC
Терапевтична област:
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Каталог на резюме:
Active ingredient group (AIG) number: 0257270001; AHFS:
Статус Оторизация:
APPROVED
Дата Оторизация:
2020-10-08
Данни за продукта
Page 1 of 47
PRODUCT MONOGRAPH
PAIN RELIEVER & SLEEP AID
Naproxen Sodium 220 mg and Diphenhydramine Hydrochloride 25mg Tablets
Apotex Inc.
150 Signet Drive
Toronto, Ontario
Canada M9L 1T9
Date of Preparation:
September 30, 2020
Control No. 230683
Page 2 of 47
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................
3
SUMMARY PRODUCT INFORMATION
.................................................................................................
3
CONTRAINDICATIONS
............................................................................................................................
3
WARNINGS AND PRECAUTIONS
...........................................................................................................
4
ADVERSE REACTIONS
.............................................................................................................................
7
DRUG INTERACTIONS
...........................................................................................................................
12
DOSAGE AND ADMINISTRATION
.......................................................................................................
14
OVERDOSAGE...........................................................................................................................................
15
ACTION AND CLINICAL
PHARMACOLOGY......................................................................................
15
STORAGE AND STABILITY
...................................................................................................................
18
SPECIAL HANDLING INSTRUCTIONS
................................................................................................
18
DOSAGE FORMS, COMPOSITION AND PACKAGING
......................................................................
18
PART II: SCIENTIFIC INFORMATION
.............................................................................................
20
PHARMACEUTICAL INFORMATION
........
Прочетете целия документ
